Effects of patent ductus arteriosus on left ventricular output and organ blood flows in preterm infants with respiratory distress syndrome treated with surfactant.
about
Chest shielding for prevention of a haemodynamically significant patent ductus arteriosus in preterm infants receiving phototherapySurgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infantsChest shielding for prevention of a haemodynamically symptomatic patent ductus arteriosus in preterm infants receiving phototherapyProphylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infantsSurgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infantsEvidence-based use of indomethacin and ibuprofen in the neonatal intensive care unitRole of prophylactic surgical ligation of patent ductus arteriosus in extremely low birth weight infants: Systematic review and implications for clinical practiceDevelopment of left ventricular longitudinal speckle tracking echocardiography in very low birth weight infants with and without bronchopulmonary dysplasia during the neonatal period.Cardiovascular magnetic resonance of cardiac function and myocardial mass in preterm infants: a preliminary study of the impact of patent ductus arteriosus.A preliminary study of the application of the transductal velocity ratio for assessing persistent ductus arteriosus.Superior mesenteric artery blood flow velocity in small for gestational age infants of very low birth weight during the early neonatal period.Prolonged low-dose indomethacin therapy for patent ductus arteriosus in very low birthweight infants.Timing of surgical ligation and morbidities in very low birth weight infants.Noninvasive technique for the diagnosis of patent ductus arteriosus in premature infants by analyzing pulse wave phases on photoplethysmography signals measured in the right hand and the left foot.Early surgical ligation versus a conservative approach for management of patent ductus arteriosus that fails to close after indomethacin treatmentChange in blood pressure and pulse pressure in preterm infants after treatment of patent ductus arteriosus with indomethacinSeverity of the ductal shunt: a comparison of different markersDoes primary surgical closure of the patent ductus arteriosus in infants <1500 g or ≤32 weeks' gestation reduce the incidence of necrotizing enterocolitis?Repeatability of echocardiographic parameters to evaluate the hemodynamic relevance of patent ductus arteriosus in preterm infants: a prospective observational study.Mechanisms regulating the ductus arteriosus.Patent ductus arteriosus: lack of evidence for common treatments.Patent ductus arteriosus in preterm infants: do we have the right answers?Patent ductus arteriosus in the preterm infant: to treat or not to treat?Patent ductus arteriosus in preterm infants.The potential and promise of mefenamic acid.Management of patent ductus arteriosus in preterm infants--where do we stand?Acute kidney injury in ELBW infants (< 750 grams) and its associated risk factors.The persistently patent arterial duct in the premature infant.Pharmacological closure of the patent ductus arteriosus.Perinatal outcome comparing triplets and singleton births at a reference maternity hospital.Indomethacin prophylaxis revisited: changing practice and supportive evidence.Correlation of B-type natriuretic peptide levels and echocardiographic parameters in preterm infants with patent ductus arteriosus.Towards rational management of the patent ductus arteriosus: the need for disease staging.Which to measure, systemic or organ blood flow? Middle cerebral artery and superior vena cava flow in very preterm infants.Early ductal shunting and intraventricular haemorrhage in ventilated preterm infantsEchocardiographic assessment of patent ductus arteriosus shunt flow pattern in premature infants.Early echocardiographic prediction of ductal closure in neonates ≤ 30 weeks gestation.Cardiac troponin T and cardiac dysfunction in extremely low-birth-weight infants.Treatment and Nontreatment of the Patent Ductus Arteriosus: Identifying Their Roles in Neonatal Morbidity.Factors affecting postnatal changes in serum creatinine in preterm infants with gestational age <32 weeks.
P2860
Q24187993-46BCAFE9-37D0-4B99-9F7E-2ABDE83BAE48Q24198805-DA0039F1-0EE8-468A-8A43-B25D7667421DQ24200802-61F333D9-0564-4463-8395-24A33B8DCF81Q24242009-E40E7612-BF78-448A-9BDB-E16AB02B3F96Q24242627-E86D871F-B2DE-4195-BCDE-E5E764BDFAF9Q24604121-B5F612F3-BA54-4B57-9798-D23441CE2A46Q24631088-9BFADF28-6E22-46D6-82BB-67F626CD3BFBQ30431410-883891CF-8D7A-41CC-9012-84FD5EA67237Q30432269-2254B484-2719-4C59-B817-2D8CCD8401D1Q30495133-B9C98499-CCC5-430E-BC9F-B266F097191CQ30656889-34994954-F0EC-4A17-A46C-52FB1135D311Q33498717-96F310EF-3899-4D99-99B5-F14E615A6CDDQ33621364-5992DB22-D6E0-441A-801B-53BD26CD1AB9Q33706781-1FD1C881-3A2F-43D6-AF75-FBDCDA4DA285Q34079478-44B4FCDA-8D08-4B1D-9919-77FF371D58DAQ34993759-52F0AEE8-D1FC-435D-8582-AE602DE2E80AQ35297500-BBE88FA5-14C4-4F33-8935-2B1633C70384Q35779724-03FCD98A-E88E-4108-82D7-AAE3DDC5572EQ35904522-0BC9B16F-1E64-4425-9B43-738628D3FAD9Q36504550-3479FA3B-0152-4C8E-BB56-F1E25A21D82DQ36977136-953AB0CD-EE05-4876-8155-DD5608D8ACAEQ37451050-8173611F-3F82-4958-96BF-0243DFBC8AC6Q37793846-4447D722-EEE6-402D-B54A-34E8B353579CQ37870606-351A3D68-CBAC-4895-96B2-E91F0FDCB4A6Q38105148-CE8E2DDD-C1A4-4592-B337-6C3E54DFCBC1Q38152796-EF161D60-9B4B-47C0-84BD-9A729A1020A6Q38693379-F2B348A4-BE51-4CF1-91CD-6F65A57B1F2BQ39652304-AC558EEB-B6B7-481B-9335-2E0C56182A7BQ39653317-DB5478E0-07AF-4E12-ACB9-44A9443301F7Q39752261-377ACB07-06FF-474D-B3AB-6A92D222A353Q39787562-6E587E94-59B4-43B3-8A18-4DE0EA5367FCQ41497125-AF1098FD-D8AD-4138-A2DB-CCF4FD017EE9Q41951843-4225C937-75AE-4E16-A3CC-2689A0F0D04CQ41960710-D3C21BC2-E537-45C5-BE9D-7CF43E6771E2Q42079680-A287F62C-DD4D-404D-85EC-836F8A543C4BQ42130958-46B217A3-1C6C-4FB7-A135-9D28746C8862Q44734078-93A7FA19-E0A3-4BC1-966D-346665B36EFEQ44921672-90D2CC45-6E1D-4887-B6A7-EACD0AC98B6CQ46123190-39F0F39B-C5A5-42F6-AC71-47E39A26E316Q46200317-1A3CF162-8F9C-4635-9BA5-C4D0A9F738C3
P2860
Effects of patent ductus arteriosus on left ventricular output and organ blood flows in preterm infants with respiratory distress syndrome treated with surfactant.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Effects of patent ductus arter ...... drome treated with surfactant.
@en
Effects of patent ductus arter ...... drome treated with surfactant.
@nl
type
label
Effects of patent ductus arter ...... drome treated with surfactant.
@en
Effects of patent ductus arter ...... drome treated with surfactant.
@nl
prefLabel
Effects of patent ductus arter ...... drome treated with surfactant.
@en
Effects of patent ductus arter ...... drome treated with surfactant.
@nl
P2093
P1476
Effects of patent ductus arter ...... drome treated with surfactant.
@en
P2093
P304
P356
10.1016/S0022-3476(94)70210-1
P407
P577
1994-08-01T00:00:00Z